TetraLogic Pharmaceuticals Corp (TLOG)

[TuesdaySmall]

Interesting updates regarding remetinostat on Medivir site

http://www.medivir.se/v5/en/RnD/proj_Remetinostat.cfm

Nick Taylor from FB wrote this a few months ago regard Remetinostat. I’m my opinion things are lining up and those attempting to screw retail stakeholders will end up very wealthy when TLOG’s former assets move forward.

“When Medivir bought the asset last year it predicted it could win approval with a phase 3 program of “modest size and cost,” but that it was unlikely to bring remetinostat to market before 2021.

If Medivir can execute that plan, it thinks a market worth $900 million in the U.S. will open up.”